| Filed On | Filing |
|---|---|
| 13 May 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The purpose of this Second Amended and Restated 2017 Equity Incentive Plan (the “Plan”) of X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Compa... |
| 26 Jan 2022 | 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more |
| 18 Oct 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 17 May 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 13 May 2019 | 8-K/A: Financial Statements and Exhibits |
| 03 Apr 2019 | 8-K/A: Financial Statements and Exhibits |
Loading...
